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The dysfunction of multiple neurotransmitter systems is a striking
pathophysiological feature ofmanymental disorders, schizophrenia
in particular, but delineating the underlying mechanisms has been
challenging. Here we show that manipulation of a single schizo-
phrenia susceptibility gene, dysbindin, is capable of regulating both
glutamatergic and dopaminergic functions through two indepen-
dent mechanisms, consequently leading to two categories of clini-
cally relevant behavioral phenotypes. Dysbindin has been reported
to affect glutamatergic and dopaminergic functions as well as a
range of clinically relevant behaviors in vertebrates and inverte-
brates but has been thought to have a mainly neuronal origin. We
ﬁnd that reduced expression ofDrosophila dysbindin (Ddysb) in pre-
synaptic neurons signiﬁcantly suppresses glutamatergic synaptic
transmission and that this glutamatergic defect is responsible for
impaired memory. However, only the reduced expression of Ddysb
in glial cells is the cause of hyperdopaminergic activities that lead to
abnormal locomotion and altered mating orientation. This effect is
attributable to the altered expression of a dopamine metabolic en-
zyme, Ebony, in glial cells. Thus, Ddysb regulates glutamatergic
transmission through its neuronal function and regulates dopamine
metabolism by regulating Ebony expression in glial cells.
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Schizophrenia is a debilitating mental disorder with intricateetiology and multidimensional pathophysiological and clinical
features. Pathophysiologically, multiple neurotransmitter systems,
including glutamate, dopamine, GABA, and serotonin, are dis-
turbed in this morbid condition (1). Accordingly, schizophrenia has
multiple clinical characteristics, including positive symptoms, nega-
tive symptoms, and cognitive impairments (2). However, how an
imbalance ofmultiple neurotransmitter systems evolves and how the
pathophysiological abnormalities give rise to the clinical features
remain to be elucidated. Despite the complicated pathophysiology
and associated symptoms, evidence is mounting that genetic factors
contribute substantially to the development and expressionof schizo-
phrenia (3). Human genetic studies have identiﬁed a plethora of
candidate genes linked to susceptibility for this disease (4). Notably,
many susceptibility genes act by regulating the function or homeo-
stasis of multiple neurotransmitter systems (5). Therefore, genetic
manipulation of these susceptibility genes will help disclose the
mechanisms underlying the genetic regulation of neurotransmitter
systems as well as related behaviors and in turn will increase our
understanding of the pathogenesis of the disease per se.
For this purpose, the current study began with an analysis of
a Drosophila mutant of dysbindin (Ddysb), an ortholog of the hu-
man schizophrenia susceptibility gene, dystrobrevin binding protein
1 (DTNBP1, also known as “dysbindin”). The DTNBP1-encoded
dysbindin-1 was identiﬁed initially as a member of the dystrophin-
associated protein complex (6) and later as a member of the
biogenesis of lysosome-related organelles complex 1 (BLOC-1)
(7). Despite some controversial results, the association between
multiple variants in DTNBP1 and schizophrenia has been repli-
cated by several independent studies (8, 9). Furthermore, reduced
dysbindin expression has been reported in the prefrontal cortex
and hippocampus of schizophrenia patients (10, 11). Although it is
a null mutant, the spontaneously occurring deletion in the mouse
homolog ofDTNBP1 (7) leads to a range of schizophrenia-related
pathophysiological and behavioral phenotypes, including reduced
glutamatergic transmission, abnormalities in dopaminergic ac-
tivities, locomotor hyperactivity, social withdrawal, and memory
compromise (12, 13).
This study of the Drosophila mutant demonstrates that a 30–
40% reduction in Ddysb expression is capable of recapitulat-
ing major features of schizophrenia-related pathophysiological
changes observed in the null mutant of the so-called “sandy”
mouse. Genetic manipulation allowed us to reveal distinct func-
tions of Ddysb in neurons and in glial cells. Disruption of Ddysb
function in neurons is responsible for hypoglutamatergic trans-
mission and subsequent memory defects, whereas disruption of
Ddysb function in glial cells causes hyperdopaminergic activity and
locomotor hyperactivity via the reduction of the protein Ebony.
Results
Characterization of the Ddysb Mutant. The Ddysb mutant studied
here is a pBace01028 mutant carrying a piggyBac transposon in the
3′ UTR of Ddysb (Fig. 1A). Western blotting revealed that Ddysb
expression in the adult head was reduced by ∼40% in this mutant
(Fig. 1B). Immunohistochemistry also showed a consistent re-
duction of Ddysb signals in the mutant brain (Fig. S1A). In ac-
cordance with a recent report (14), these results suggest that
pBace01028 is a hypomorphic allele ofDdysb and thus is referred to
hereafter as “dysb1.”
We ﬁrst looked at pathophysiology-related changes, i.e., glu-
tamatergic and dopaminergic activities. The two-electrode volt-
age-clampmethod was used to assay excitatory junctional currents
(EJCs) of glutamatergic synaptic transmission at the well-char-
acterized larval neuromuscular junction (NMJ) (15). The dysb1
mutant showed signiﬁcantly attenuated EJCs at various extracel-
lular calcium concentrations (Fig. 1C) without signiﬁcant morphol-
ogical changes; this result is consistent with a recent indepen-
dent study (14). To assay how dopamine activity might be affected,
we measured the dopamine level in the heads of adult ﬂies using
ELISA (16). The dopamine concentration in dysb1 mutant heads
was around twofold of that in WT ﬂies (Fig. 1D). Therefore, re-
duced Ddysb expression leads to both hypoglutamatergic and
hyperdopaminergic activities.
For pathophysiology-relevant behavioral phenotypes, we fo-
cused mainly on learning task and locomotor activity, because
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both are often assayed in rodentmodels of schizophrenia (17). For
the learning task, adult ﬂies were trained with Pavlovian olfactory
aversive conditioning in which ﬂies learn to avoid an odor pre-
viously associated with electric shock (Fig. 1E, Left) (18, 19).
Memory performance immediately after one-session training was
lower in dysb1mutants than inWT ﬂies. Memory retention at later
time points, either 3 h after single-session training or 24 h after
repetitive training, was also compromised in the dysb1 mutant
(Fig. 1E, Right), but the sensorimotor responses necessary for
performing the learning task were not altered (Fig. S1 B and C).
For locomotor activity, we used a climbing assay to record how
high ﬂies climbed in response to light taps on the container (Fig.
1F, Left) (20). The dysb1 mutant exhibited remarkably elevated
activity compared with WT ﬂies of the same age (Fig. 1F, Right).
During the climbing assay, we observed that dysb1 males showed
abnormal male–male courtship behavior. Mutant males courted
females, as WT ﬂies do (Fig. S1D), but also oriented the typical
courtship ritual toward another male. To quantify this abnormal
mating orientation, we adopted amating preference assay, in which
the testing male was allowed to choose between a decapitated WT
male and female as amating partner (Fig. 1G,Left) (21).WTmales
display a strong bias toward female ﬂies, but this courtship tendency
was reduced signiﬁcantly in the dysb1 mutants (Fig. 1G, Right).
Thus dysb1 mutants showed hypoglutamatergic and hyper-
dopaminergic activities as well as memory defects, locomotor
hyperactivity, and mating disorientation. The genetic speciﬁcity
of the observed phenotypes was conﬁrmed through rescuing and
RNAi silencing experiments presented later.
Tissue-Speciﬁc Regulation of Changes in Neurotransmitter Systems.
While determining the genetic speciﬁcity of the observed phe-
notypes, we discovered tissue-speciﬁc functions ofDdysb using the
Gal4/Upstream Activation System (Gal4/UAS) binary system
(22). Ddysb RNAi (DdysbIR) and UAS-Ddysb ﬂies were used for
Ddysb knockdown and overexpression (Fig. S2). At the NMJ, we
ﬁrst determined whether glutamatergic transmission was sup-
ported by a presynaptic or postsynaptic function of Ddysb.
Transgenic RNAi was targeted to either presynaptic neurons or
postsynaptic muscle cells. We found that silencing Ddysb func-
tions pan-neuronally [embryonic lethal abnormal vision (elav)-
Gal4/Y;DdysbIR-1/+], instead of in the muscle cells (DdysbIR-1/+;
muscle Gal4 (C57)/+), caused a similarly reduced EJC amplitude
in the dysb1 mutant (Fig. 2A). To conﬁrm further the presynaptic
role of Ddysb, we performed a rescuing experiment, showing that
pan-neuronal expression of theUAS-Ddysb transgene in the dysb1
mutant background (elav-Gal4/Y;UAS-Ddysb/+;dysb1) success-
fully restored the EJC to the WT level (Fig. 2B). Moreover, pan-
neuronal overexpression of Ddysb by two copies in the WT
background (elav-Gal4;UAS-Ddysb) led to increased EJC ampli-
tude (Fig. S3A). Thus, Ddysb regulates the glutamatergic synaptic
transmission presynaptically in a dosage-dependent manner.
Unexpectedly, the neuronal expression of Ddysb in dysb1 mu-
tant (UAS-Ddysb/+;elav-Gal4(III) dysb
1/dysb1) did not rescue the
dopamine level in the adult head (Fig. 2C, Left). This result
prompted us to test the possibility that Ddysb might have non-
neuronal functions.We found that expression ofDdysbwith a glia-
speciﬁc driver, Reversed polarity (Repo)-Gal4 (UAS-Ddysb/+;
Repo-Gal4 dysb1/dysb1) suppressed the elevated dopamine level in
the dysb1 mutant (Fig. 2C, Right). Therefore, Ddysb appears to
regulate glutamatergic transmission and dopamine level through
different mechanisms. This result led us to explore whether and
how such distinct roles affect relevant behavioral phenotypes.
Tissue-Speciﬁc Regulation of Different Behaviors. Pan-neuronal ex-
pression of Ddysb in the mutant background (UAS-Ddysb/+;elav-
Gal4(III) dysb
1/dysb1) rescued the short-termmemory defect in the
dysb1 mutant (Fig. 2D, Left), whereas glial expression (UAS-
Ddysb/+;Repo-Gal4 dysb1/dysb1) failed to do so (Fig. 2D, Right).
Furthermore, pan-neuroanl overexpression of Ddysb (elav-
Gal4/+;UAS-Ddysb/+) led to a similar defect inmemory (Fig. S3B).
Thus, all the data consistently supported the notion that intact
Ddysb function in neurons is required for memory formation.
In contrast to the memory deﬁcit, locomotor hyperactivity and
the mating disorientation in the dysb1 mutant were suppressed by
expressing Ddysb in glia (UAS-Ddysb/+;Repo-Gal4 dysb1/dysb1)
but not in neurons (UAS-Ddysb/+;elav-Gal4(III) dysb
1/dysb1) (Fig.
2 E and F). The speciﬁcity of this glial rescue was conﬁrmed fur-
ther via targeted RNAi silencing. Knocking down Ddysb pan-
neuronally (elav-Gal4/Y;DdysbIR-1/+) had no effect on themating
orientation of males. However, expressing DdysbIR either ubiqui-
tously (Actin-Gal4/DdysbIR-1) or speciﬁcally in glia (DdysbIR-1/+;
Repo-Gal4/+) resulted in dramatically increased male–male
courtship behavior, as shown in the dysb1 mutant (Fig. S3C).
Human Dysbindin Rescues the Phenotypes in dysb1 Mutant. Ddysb
shares 28% amino acid identity with human dysbindin-1 (Hdysb)
(9), but it remains unknown whether the functions of dysbindin
are conserved and whether the Hdysb also has the tissue-speciﬁc
effects revealed above. Thus, we generatedUAS-Hdysb transgenic
ﬂies (Fig. S4). Pan-neuronal expression of Hdysb successfully re-
stored the glutamatergic transmission (elav-Gal4/Y;UAS-Hdysb/+;
dysb1) and associative memory (UAS-Hdysb/+;elav-Gal4(III)
dysb1/dysb1) in the dysb1 mutant (Fig. 2 G and I), whereas glial
expression of Hdysb (UAS-Hdysb/+;Repo-Gal4 dysb1/dysb1) sup-
pressed the elevated brain dopamine level and hyperactivity (Fig.
2H and J). Thus, the evidence suggests considerable conservation
between human and Drosophila dysbindin in function.
Endogenous Expression of Ddysb in Glial Cells. Earlier studies on
dysbindin focused largely on its neuronal function (8). However,
Fig. 1. Characterization of the Ddysbmutant. (A) Transposon insertion site.
(B) Representative Western blots and group data showing reduced expres-
sion of Ddysb in the head of the dysb1 mutant (t test; P = 0.007; n = 5). (C)
The dysb1 mutant shows decreased EJC amplitude (t test; P = 0.002, 0.02,
0.03, and 2.1E-6 for calcium concentrations of 0.15, 0.2, 0.3, and 0.4 mM,
respectively; n = 7–14). (D) Dopamine concentration in whole-head extracts
of adult ﬂies is elevated signiﬁcantly in the dysb1 mutant (t test; P = 1.9E-6;
n = 8–10). (E) The dysb1 mutant shows memory defects in the Pavlovian ol-
factory aversive conditioning (t test; P = 0.004, 0.002, and 0.009; n = 7–8). The
T-maze for memory test is illustrated. (F) dysb1 mutants show dramatically
increased locomotor activity (t test; P = 2E-4; n = 17). The experimental
paradigm for the locomotion test is illustrated on the left. (G) The dysb1
mutant shows mating disorientations (t test; P = 0.02; n = 28–32). The mating
preference assay is illustrated. Data are means ± SEM. *P < 0.05; **P < 0.01;
***P < 0.001.
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the experiments described above revealed an underestimated role
of Ddysb in glia that could affect dopamine signaling, locomotion,
and sex orientation. This ﬁnding led us to map the distribution of
Ddysb in glial cells. We ﬁrst attempted to visualize Ddysb in glial
cells through immunohistochemical staining of Ddysb (in red)
over GFP-labeled glia (UAS-mCD8::GFP/+;Repo-Gal4/+). The
presence of endogenous Ddysb in glia was observed in the optic
lobes and the central brain (merged yellow for Ddysb in glia; white
arrows in Fig. 3A). To validate the detected signals, we expressed
a Venus ﬂuorescence protein (VFP)-tagged Ddysb (14) in GFP-
labeled glia (UAS-mCD8::GFP/+;UAS-venus-dysb/Repo-Gal4). A
similar pattern of Ddysb expression was observed (merged yellow
at the cell body region; white arrows in Fig. 3B). However, we
noted that a large fraction of VFP-Ddysb (red dots and white
arrowheads in the lower panels of Fig. 3B and Fig. S5) was dis-
tributed over glial processes that were not merged with the GFP-
taggedmembrane protein, suggesting that the endogenous level of
glial Ddysb was underestimated (Fig. 3A).
Although its expression in glia is scattered, Ddysb plays a critical
role in development in addition to the physiological and behav-
ioral roles described above. Silencing Ddysb speciﬁcally in glia
with two copies of DdysbIR (DdysbIR-1/DdysbIR-2;Repo-Gal4/+)
resulted in pupal lethality signiﬁcantly higher than in the parental
controls (Fig. S6). Driving even a single copy of RNAi by an astro-
like glial Gal4 (NP3233) resulted in embryonic lethality similar to
that seen with universal knockdown of Ddysb (Table S1).
Acute Induction of Ddysb Rescues the Phenotypes in dysb1 Mutants.
BecauseDdysbmight play a role in the development of the nervous
system (as discussed above, and also see ref. 23 and 24), we wanted
to determine the developmental contribution to the phenotypes
observed. To this end, we tested the effects of acutely manipulated
expression of Ddysb. Acute induction of Ddysb through a heat-
shock Gal4 (hs-Gal4) driver (UAS-Ddysb/+;hs-Gal4 dysb1/dysb1)
(Fig. S7) rescued the short-term memory defect (Fig. 4A) and
suppressed the increased brain dopamine concentration (Fig. 4B)
and the mating disorientation (Fig. 4C) in the dysb1mutant. These
results indicate that, apart from developmental functions, Ddysb
also plays an acute physiological role in regulating neurotrans-
mitters and behaviors in adult animals.
Hypoglutamate Is Responsible for Memory Defect. Because both
glutamatergic transmission at the NMJ and the memory capacity
in the adult ﬂy were restored by expressing WT Ddysb pan-neu-
ronally in the dysb1 mutant background, we were interested in
whether the function of Ddysb in glutamatergic transmission is
related to its function in memory ability. First, we found that
feeding ﬂies with glycine, a NMDA receptor agonist and also
a drug used to treat negative syndromes in schizophrenia (25),
restored memory performance to the WT level in the adult ﬂy,
Fig. 2. Tissue-speciﬁc regulation of changes in different neurotransmitter
systems and behaviors. (A) EJC amplitude was reduced signiﬁcantly by expres-
sion of the Ddysb RNAi presynaptically (elav-Gal4/Y; DdysbIR-1/+) but not post-
synaptically (DdysbIR-1/+;C57/+) (ANOVA; n = 9–16). The calcium concentration
for recording is 0.4 mM. (B) Neuronal expression of UAS-Ddysb (elav-Gal4/Y;
UAS-Ddysb/+;dysb1) rescued the EJC deﬁcit in thedysb1mutant (ANOVA;n= 16–
22). (C) Glial expression of Ddysb (UAS-Ddysb/+;Repo-Gal4 dysb1/dysb1), but not
neuronal expression of Ddysb (UAS-Ddysb/+;elav-Gal4(III) dysb
1/dysb1), restored
the brain dopamine concentration to normal levels (ANOVA; n = 5–10). (D) Pan-
neural expression of Ddysb (UAS-Ddysb/+;elav-Gal4(III) dysb
1/dysb1) is sufﬁcient
to rescue the 3-min associative memory deﬁcit in the dysb1 mutant. However,
glia-speciﬁc expression of Ddysb (UAS-Ddysb/+;Repo-Gal4 dysb1/dysb1) failed to
do so (ANOVA; n = 4–14). (E and F) Locomotor hyperactivity and mating dis-
orientation were suppressed in dysb1 mutants expressing UAS-Ddysb in glia
(UAS-Ddysb/+;Repo-Gal4 dysb1/dysb1) but not in neurons (UAS-Ddysb/+;elav-
Gal4(III) dysb
1/dysb1). (ANOVA; n = 8–10 for locomotor test; n = 22–51 formating
test.) Data aremeans± SEM. (G and I) Pan-neuronal expression ofHdysb rescued
the EJC amplitude (elav-Gal4/Y;UAS-Hdysb/+;dysb1) (ANOVA; n = 9–10) and the
3-min associative memory deﬁcit (UAS-Hdysb/+;elav-Gal4(III) dysb
1/dysb1)
(ANOVA; n = 16) in the dysb1mutant. Calcium concentration for recording is 0.4
mM. (H and J) Glial expression of Hdysb (UAS-Hdysb/+;Repo-Gal4 dysb1/dysb1)
restored the brain dopamine level (ANOVA; n = 4–11) and partially suppressed
the hyperactivity in the dysb1mutant (ANOVA; n = 10). Data are means ± SEM.
*P < 0.05; **P < 0.01; ***P < 0.001; n.s., not signiﬁcant (P > 0.05).
Fig. 3. Endogenous expression of Ddysb in glial cells. Lower row shows en-
larged views of boxed areas in upper row. (A) Ddysb is expressed extensively in
bothneuronsandglia. Immunosignals of anti-Ddysbantibody (red), representing
endogenous Ddysb, partially overlap (yellow)with Repo-Gal4–drivenmCD8::GFP
(green) at the glial cell bodies (white arrows).The dotted red signals also aggre-
gate at the boundaries of neurons and glial processes (white arrowheads). (B)
Coexpression of UAS-mCD8::GFP (green) and UAS-venus-dysb (red) in glia (UAS-
mCD8::GFP/+;UAS-venus-dysb/Repo-Gal4). The immunosignals of Repo-Gal4–
driven-Ddysb (red) localize at the glial cell body region (white arrow) and the
boundaries of neurons and glial processes (white arrowheads), similar to the
distribution of endogenous Ddysb in glia. (Scale bars: 20 μmUpper; 5 μm Lower.)
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suggesting that the hypoglutamatergia in the dysb1 mutant is re-
sponsible for its memory deﬁcit (Fig. 5A). To conﬁrm the speci-
ﬁcity of the pharmacological rescuing effect, we then expressed
Ddysb with a glutamatergic neuron-speciﬁc Gal4 driver (vesicular
glutamate transporter Gal4, VGluT-Gal4) in the mutant back-
ground (VGluT-Gal4/+;UAS-Ddysb/+;dysb1), which sufﬁciently
restored the short-term memory to the normal level (Fig. 5D).
Furthermore, overexpression of Ddysb in glutamatergic neurons
(VGluT-Gal4/+;UAS-Ddysb/+) led to a defect in memory (Fig. S8)
similar to that seen with pan-neuronal overexpression. Thus, all
the data consistently show that the intact function of Ddysb in
glutamatergic transmission is required for memory formation.
Elevated Dopamine Is Responsible for Hyperactivity and Mating
Disorientation. Because the memory defect was associated specif-
ically with Ddysb functions in glutamatergic neurons, we then
tested whether glia-dependent hyperdopaminergic activity, loco-
motor hyperactivity, andmating disorientation are related. In fact,
there are reports that hyperdopaminergia in the fruit ﬂy can
lead to male–male courtship (26) and hyperactivity (27). We fed
ﬂies with two inhibitors of dopamine signaling: the vesicular
monoamine transporter inhibitor reserpine (28) and the tyrosine
hydroxylase (TH) inhibitor α-methyl-p-tyrosine (AMPT) (29).
Compared with the drug-free group, both reserpine and AMPT
signiﬁcantly suppressed locomotor hyperactivity and mating dis-
orientation in the dysb1mutant but at the tested concentration had
no signiﬁcant effects on WT ﬂies (Fig. 5 B and C).
The speciﬁcity of the pharmacological assay was conﬁrmed by
a genetic interaction experiment betweenDdysb and ebony, which
encodes a glia-speciﬁc β-alanyl biogenic amine synthetase that
metabolically inactivates biogenic amines in the nervous system.
The dopamine sequestered by glia is inactivated by Ebony to form
N-β-alanyldopamine (NBAD) (30). Defective Ebony increases
brain dopamine level and perturbs multiple behaviors including
courtship (26, 31). As expected, we revealed a genetic interaction
between Ddysb and ebony. The locomotor hyperactivity and
mating disorientation were observed in double-heterozygous
mutants (ebony1/dysb1), although single heterozygotes (ebony1/+
or dysb1/+) showed no phenotypes (Fig. 5 E and F). Therefore,
evidence from pharmacological rescue and genetic interaction
corroborates the contribution of elevated dopamine signaling to
locomotor hyperactivity and mating disorientation.
Ddysb Regulates Dopamine Level via Ebony in Glia. To gain insights
into how Ddysb regulates dopaminergic activity in glial cells, we
examined the transcription proﬁles of major genes involved in the
synthetic and metabolic pathway of dopamine in Drosophila (Fig.
6A and refs. 32 and 33). RT-PCR results showed that, among the
genes examined, the transcription levels of pale [the genetic locus
for TH, the rate-limiting enzyme in dopamine biosynthesis (Fig.
6A and ref. 32)], and tan [encoding Tan, the enzyme for hydrolysis
of NBAD to dopamine (Fig. 6A and ref. 34)] were decreased
dramatically in dysb1 mutants (Fig. 6B). However, the changes in
expression of these two genes could not be responsible for
hyperdopaminergic activity, because (i) both TH and Tan are
expressed speciﬁcally in neurons; and (ii) their reduction is a
change in the opposite direction of producing hyperdopaminergic
activity. In addition to these two genes, expression of ebony is also
reduced signiﬁcantly at both mRNA and protein levels in the dysb1
mutant (Fig. 6 B and C). As mentioned earlier, a reduction in
Ebony function leads to hyperdopaminergic activity (26). The
genetic interaction between Ddysb and ebony (Fig. 5 E and F)
corroborates nicely with biochemical data, indicating that a re-
duction in Ddysb activity leads to reduced Ebony activity, which in
turn leads to hyperdopaminergic activity.
Further immunohistochemical analysis of the adult brain
conﬁrmed the changes in Ebony. The Ebony signals were de-
creased in both the cell body and in the processes region of the
Ebony-expressing glial cells (Fig. 6D), with more visible re-
duction in the processes.
Discussion
The current study investigated functions of Ddysb to explore how
the altered expression of a single schizophrenia susceptibility gene
relates to the pathophysiology and clinically relevant phenotypes.
The function of this gene is highly conserved from Drosophila to
vertebrates and even to humans. The observed pattern of Ddysb
expression in the Drosophila brain (Fig. 3A and Fig. S1A) is very
similar to that reported in the vertebrate brain: widespread and
enriched in neurons (6). Loss-of-function mutations and RNAi
knockdown of Ddysb in Drosophila produced phenotypes similar to
those observed in the sandy mouse, including attenuated gluta-
matergic transmission, hyperdopaminergic activity,memory defects,
and locomotor hyperactivity. Moreover, the human DTNBP1 gene
was capable of rescuing dysb1mutant phenotypes inDrosophila (Fig.
2 G–J). With the help of genetic tools exclusively available in Dro-
sophila, however, we gained surprising insights, as outlined below.
Fig. 4. Acute induction of Ddysb rescues the phenotypes in the dysb1 mu-
tant. Acute induction of Ddysb expression ubiquitously by a heat-shock
promoter–Gal4 driver in the mutant background (UAS-Ddysb/+;hs-Gal4
dysb1/dysb1) rescued the 3-min associative memory deﬁcit (A) (ANOVA; n =
6–12) and restored the brain dopamine level (B) (t test; P = 0.15; n = 7–14)
and normal mating orientation (C) (ANOVA; n = 19–24). Data are means ±
SEM. *P < 0.05; **P < 0.01; ***P < 0.001; n.s., not signiﬁcant (P > 0.05).
Fig. 5. Hypoglutamate and hyperdopamine levels are responsible for different
behavioral phenotypes. (A) Feeding ﬂies with glycine, an NMDA receptor ago-
nist, restored the3-minassociativememory in thedysb1mutant (t test;P=0.0007;
n=9–12)without signiﬁcantly affectingWTﬂies (t test; P=0.17;n=12). (B andC)
Feeding ﬂies with reserpine, a vesicular monoamine transporter inhibitor, and
AMPT, a TH inhibitor, suppressed the increased locomotion and disorientated
mating behavior in the dysb1 mutant (ANOVA; n = 9–12 for locomotor test; n =
20–57 for mating test) but did not signiﬁcantly inﬂuenceWT ﬂies. (D) Expression
of Ddysb speciﬁcally in the glutamatergic neurons (VGluT-Gal4/+;UAS-Ddysb/+;
dysb1) is sufﬁcient to rescue the 3-min associative memory deﬁcit in the dysb1
mutant (ANOVA; n = 14). (E and F) Genetic complementation test between dysb1
and ebony1 (e1) Compared with parental controls (e1/+ and dysb1/+), the double
heterozygotes (e1/dysb1) showed signiﬁcant locomotor hyperactivity (ANOVA;
n = 15–16) and mating disorientation (ANOVA; n = 34–36). Data are means ±
SEM. *P < 0.05; **P < 0.01; ***P < 0.001; n.s., not signiﬁcant (P > 0.05).
18834 | www.pnas.org/cgi/doi/10.1073/pnas.1114569108 Shao et al.
First, although Ddysb is widely expressed in the brain, restoring
Ddysb in glutamatergic neurons alone was sufﬁcient to rescue
hypoglutamatergic transmission and memory defects. Second,
Ddysb’s functions in glial cells are essential for normal dopami-
nergic activity and associated behaviors, including locomotion and
mating orientation. Third, all observed pathophysiological and
behavioral phenotypes were rescued with acute genetic or phar-
macological treatments in adults.
We devoted special attention to validating the phenotypes ob-
served, including maintaining an isogenic background for all
genotypes (Materials and Methods), balancing the behavioral assays
(19), and conﬁrming themanifested phenotypes by different genetic
manipulations (mutations, genetic rescuing, and RNAi knock-
down). In the following sections, we address the signiﬁcance and
implications of our ﬁndings.
Glutamatergic Functions and Memory Defects. An increasing num-
ber of studies suggest that genetic variation inDTNBP1 in normal
human populations affects verbal and visual memories as well as
working memory (35, 36). This association is supported by studies
on the sandymouse, which is defective in a range of memory tasks,
including spatial memory, novel object recognition, and contex-
tual fear conditioning (12, 13). However, the physiological causes
of such memory defects are not clearly deﬁned.
In this study, we show that altered Ddysb function in gluta-
matergic neurons alone is responsible for attenuated gluta-
matergic transmission and for the memory defect. It is interesting
that this memory defect is not a developmental phenotype and
could be rescued acutely both by feeding ﬂies with the NMDA
receptor agonist glycine (Fig. 5A) and by expressing Ddysb only in
glutamatergic neurons (Fig. 5D). Such a result is consistent with
reports showing that NMDA receptors in theDrosophila brain are
involved in memory formation (37, 38).
Glial Functions and Regulation of Dopaminergic Activity. Before the
current study, the expression and function of dysbindin were con-
sidered to occur primarily, if not exclusively, in neurons (8).
However, recent reports have demonstrated that in mouse and rat
brains the expression level of dysbindin in glia is comparable with, if
not higher than, its expression in neurons (23, 39), although its glial
functions remained to be determined. Genetic tools available for
Drosophila allowed us not only to deﬁne the function of dysbindin
in glia but also to gain insight into the underlying mechanisms.
Anatomically, we showed that immunohistochemical signals of
Ddysb (in red) were detected in glial cells labeled by GFP-tagged
membrane proteins, with sparse Ddysb distribution in cell bodies
and the majority of glial Ddysb signals in glial processes or in thin
layers surrounding individual neuronal cell bodies (Fig. 3A). This
observation was supported by the distribution pattern of VFP-
tagged Ddysb in GFP-labeled glial cells (Fig. 3B and Fig. S5).
Evidence supporting a functional role of Ddysb in glia is very
strong. We showed that the escalated dopamine level in the dysb1
mutant could be rescued by targeted expression of the Ddysb or
humanDTNBP1 transgeneonly in glial cells but not in neurons (Fig.
2 C andH). In addition, the hyperdopaminergia-elicited behaviors,
including locomotor hyperactivity and mating disorientation, were
rescued only through targeted glial expression of Ddysb or human
DTNBP1 transgenes (Fig. 2 E, F, and J). More convincingly, knock-
ing down Ddysb universally or in glia but not in neurons resulted in
embryonic or pupal lethality, respectively (Fig. S6 and Table S1).
Our further investigation suggests that mutations ofDdysb cause
hyperdopaminergic activity by down-regulating the expression of
Ebony. Our biochemical data proﬁling mRNA and protein ex-
pression corroborated well with genetic observations, supporting
the idea that Ebony plays critical role in mediating the effects of
Ddysb in glial cells. It is likely that this Ddysb/Ebony-produced
hyperdopaminergic activity somehow leads to reduced TH and
Tan expression in neurons through a negative feedback mecha-
nism for maintaining the homeostasis of dopaminergic activity.
How Ddysb regulates expression of Ebony remains to be de-
termined. One possibility comes from reports that human dys-
bindin can function as a nucleocytoplasmic shuttling protein that
regulates the transcription of several genes either directly or by
binding with other transcription-related factors (40–42). Here, we
analyzed the Ddysb protein sequence with the PSORT II Pre-
diction WWW Server (http://psort.ims.u-tokyo.ac.jp/form2.html)
and found that the probability that Ddysb localizes to the nucleus
is 94.1%. Thus, it is plausible that Ddysb in glia plays a role in
regulating gene transcription.
Alternatively, Ddysb might regulate the dopamine level in glial
cells by affecting the stability of the Ebony protein. The dysbindin-
containing BLOC-1 complex is a component of the endosomal
protein sorting and compartmental machinery (43, 44). Abnor-
malities in Ebony protein sorting may lead to abnormalities in
ubiquitylation, protein instability, or malfunction of the enzyme.
Implications for Disease. Although the possibility of generating ﬂy
models of schizophrenia has been raised recently (45), the intent of
this study is not to model schizophrenia in Drosophila. Instead, we
are interested in whether and how a single mild genetic alteration,
similar to those observed in cases of schizophrenia, gives rise to
complex phenotypes at the neurotransmitter regulation and be-
havioral levels. Our study led to two interesting observations.
Fig. 6. Ddysb regulates dopamine level via Ebony in glial cells. (A) Dopamine
(DA) synthetic and metabolic pathway. The actions of proteins, their encod-
ing genes, and inhibitors are shown. DAT (dopamine transporter) is a dopa-
mine transmembrane transporter. Dat (dopamine N acetyltransferase) is an
N-acetyltransferase to metabolize dopamine to N-acetyl-dopamine. VMAT
(vesicular monoamine transporter) is a synaptic vesicle amine transmembrane
transporter. (B) Representative RT-PCR and group data show decreased
mRNA levels of ebony (e), pale (ple), and tan (t) in the dysb1mutant (t test; P =
0.02, 1.7E-5, and 0.02; n = 4), whereas the transcripts of DAT and Dat did not
have signiﬁcant changes compared withWT. (C) RepresentativeWestern blot
and group data showing decreased Ebony protein level in the dysb1 mutant
(t test; P = 0.002; n = 7). (D) Ebony is expressed in glial cells. Neuropils were
stained with mAb nc82 (magenta). Ebony immunosignals (green) were
weaker in the dysb1 mutant than in the WT. (Scale bars: 40 μm Left; 20 μm
Right.) *P < 0.05; **P < 0.01; ***P < 0.001; n.s., not signiﬁcant (P > 0.05).
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First, we were surprised to see that a rather mild 30–40%
reduction in Ddysb expression led to signiﬁcant alterations in
both glutamatergic transmission and dopaminergic activity. Most
schizophrenia susceptibility genes reported to date are identiﬁed
not from mutations but from single-nucleotide polymorphisms or
haplotypes, which are believed to produce only mild alterations
at the gene expression level (5). It therefore is debatable how
strong the contribution of an individual genetic variant is and
whether multiple genetic components acting in concert are
needed for the effects. Here we show that a mild reduction of at
least one of the susceptibility genes is sufﬁcient to cause complex
changes in multiple neurotransmitter systems through very dif-
ferent mechanisms. Our ﬁndings suggest that these susceptibility
genes might play such critical roles in neurotransmitter regula-
tion that a mild change in expression is sufﬁcient to cause de-
tectable behavioral phenotypes.
Second, although a developmental role of dysbindin has been
reported earlier (23, 24) and is supported, as mentioned above (Fig.
S6 and Table S1), both neurotransmitter and behavioral phenotypes
examined in this study could be rescued through acute treatments
(Figs. 4 and 5 A–C). Schizophrenia is considered a neurodevel-
opmental disorder (46), a notion that is supported by animal model
studies of development and by genetic mouse models of neuro-
developmental candidate genes and susceptibility genes (47). How-
ever, this study suggests that, to some extent, some of the genetically
relevant phenotypes are reversible or could be treated in adults.
Materials and Methods
Fly stocks and detailed procedures for the generation of constructs and
antibody, germ-line transformation, Western blot, RT-PCR, electrophysiol-
ogy, drug treatments, dopamine level determination, immunohistochemis-
try, heat-shock regimen, and behavior assays including Pavlovian olfactory
conditioning, the locomotor activity test, mating orientation test, and sta-
tistical analysis are described in SI Materials and Methods.
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